KCT0009027
Not yet recruiting
未知
Efficacy of early rhythm control therapy in patients with subclinical atrial fibrillation
ConditionsDiseases of the circulatory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the circulatory system
- Sponsor
- Samsung Medical Center
- Enrollment
- 520
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Among patients with Cardiac implantable electronic device (CIED), subjects with atrial high rate episodes found
- •\- Cardiac implantable electronic devices: implantable loop recorder, pacemaker, implantable cardioverter defibrillator(ICD), cardiac resynchronized therapy(CRT)
- •1\) Patients aged 19 or older who have agreed to the study (if voluntary consent is deemed difficult, consent from legal representatives is obtained together)
- •2\) If the accumulated period of the atrial high rate episode during the three\-month observation period is more than 24 hours
- •3\) Patients whose atrial fibrillation has not been confirmed by electrocardiogram or holter monitoring within the past year from the time atrial high rate episode was detected
- •However, enrollment is possible even if it includes one of the following two cases
- •? Patients diagnosed and recorded as atrial fibrillation on medical records but not confirmed by electrocardiogram or holter monitoring
- •? If there is a record of atrial fibrillation, but Paroxysmal AF less than 30 seconds
Exclusion Criteria
- •1\) Patients deemed inappropriate to participate in the study by the investigator
- •2\) Patients diagnosed with atrial fibrillation with 12\-lead electrocardiogram or holter within the past year prior to participation in the study
- •3\) Patients taking Class Ic, III of antiarrhythmic drugs prior to study participation
- •4\) Patients who have had rhythm control treatments such as Radiofequency catheter ablation (RFCA), Total thoracoscopic ablation (TTA), Maze procedure (MAZEop), and antiarrhythmic treatment due to atrial fibrillation (except for CTI ablation with AFL)
- •5\) Patients whose life expectancy is less than one year (e.g., patients who can't even have a heart transplant, patients who receive DNR, Patients in hospice wards who refuse life\-sustaining treatment, terminal cancer patients who cannot receive radiation or chemotherapy, etc.)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Heart function assessment in atrial fibrillation patientsHealth Condition 1: I481- Persistent atrial fibrillationCTRI/2024/03/064245Kasturba Medical College, Manipal Academy of Higher education, Manipal
Not yet recruiting
Not Applicable
Assessment of cardiac resynchronization therapy in patients with wide QRS-complex and non-specific intraventricular conduction delay: a randomized trial.NL-OMON54616Clermont-Ferrand University Hospital30
Not yet recruiting
Not Applicable
Effects of Cardiac Resynchronization Therapy on the Microcirculation (CaRe-Mi)alterations of microcirculationchronic heart failureweak heart10019280NL-OMON32204Academisch Medisch Centrum51
Not yet recruiting
Not Applicable
Effect of Exercises In Patients with Adhesive capsulitisHealth Condition 1: - Health Condition 2: M750- Adhesive capsulitis of shoulderCTRI/2022/09/045767MuditaKulkarni
Completed
Not Applicable
Study on the efficacy of speed feedback therapy system incorporating upper and lower extremities ergometer on the cognitive function of older adults with dementiadementiaJPRN-UMIN000022344Hiroshima University112